Predict of efficacy of GnRHagonist treatment for uterine leiomyoma using PET
Project/Area Number |
21791177
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Radiation science
|
Research Institution | University of Fukui |
Principal Investigator |
CHINO Yoko 福井大学, 医学部附属病院, 医員 (40436845)
|
Project Period (FY) |
2009 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | 核医学(PET を含む) / ホルモン療法 / FES-PET / 子宮筋腫 / GnRHagonist / PET / FES / FDG-PET |
Research Abstract |
We tried to predict the efficacy of GnRHagonist treatment foruterine leiomyoma by FES(16α-[18^F]fluoro-17β-estradiol)-PET and 18^F-FDG PET.3 of thirteen patients were markidly effective . Those FES-SUV value were higher thanother patients. The patient with high FES-SUV value is effective by GnRHagonist therapy.
|
Report
(4 results)
Research Products
(9 results)